Clinical Trial Update: Vascular Effects of Alirocumab in Acute MI-Patients [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating vascular effects of alirocumab in acute myocardial infarction patients; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atheroma of Coronary Arteries
• Coronary Circulation Disorders
• Coronary Vessel Disease
• Myocardial Infarction

Drugs mentioned

• alirocumab (alirocumab)

Snippet

Sponsor: Insel Gruppe AG, University Hospital Bern | Conditions: Coronary Vessel, Coronary Circulation | Phase 3 | Status: COMPLETED